Literature DB >> 9256429

SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.

S H Hong1, G David, C W Wong, A Dejean, M L Privalsky.   

Abstract

Retinoic acid receptors (RARs) are hormone-regulated transcription factors that control key aspects of normal differentiation. Aberrant RAR activity may be a causal factor in neoplasia. Human acute promyelocytic leukemia, for example, is tightly linked to chromosomal translocations that fuse novel amino acid sequences (denoted PML, PLZF, and NPM) to the DNA-binding and hormone-binding domains of RARalpha. The resulting chimeric receptors have unique transcriptional properties that may contribute to leukemogenesis. Normal RARs repress gene transcription by associating with ancillary factors denoted corepressors (also referred to as SMRT, N-CoR, TRAC, or RIP13). We report here that the PML-RARalpha and PLZF-RARalpha oncoproteins retain the ability of RARalpha to associate with corepressors, and that this corepressor association correlates with certain aspects of the leukemic phenotype. Unexpectedly, the PLZF moiety itself can interact with SMRT corepressor. This interaction with corepressor is mediated, in part, by a POZ motif within PLZF. Given the presence of POZ motifs in a number of known transcriptional repressors, similar interactions with SMRT may play a role in transcriptional silencing by a variety of both receptor and nonreceptor transcription factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256429      PMCID: PMC23013          DOI: 10.1073/pnas.94.17.9028

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.

Authors:  W Seol; M J Mahon; Y K Lee; D D Moore
Journal:  Mol Endocrinol       Date:  1996-12

Review 2.  What's up and down with histone deacetylation and transcription?

Authors:  M J Pazin; J T Kadonaga
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 3.  Nuclear receptor coactivators and corepressors.

Authors:  K B Horwitz; T A Jackson; D L Bain; J K Richer; G S Takimoto; L Tung
Journal:  Mol Endocrinol       Date:  1996-10

4.  Transcriptional control. Sinful repression.

Authors:  A P Wolffe
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

5.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.

Authors:  H de Thé; C Chomienne; M Lanotte; L Degos; A Dejean
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

6.  Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors.

Authors:  S M Yoh; V K Chatterjee; M L Privalsky
Journal:  Mol Endocrinol       Date:  1997-04

7.  Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.

Authors:  J L Grisolano; R L Wesselschmidt; P G Pelicci; T J Ley
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

8.  A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.

Authors:  D Brown; S Kogan; E Lagasse; I Weissman; M Alcalay; P G Pelicci; S Atwater; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice.

Authors:  G David; B Terris; A Marchio; C Lavau; A Dejean
Journal:  Oncogene       Date:  1997-04-03       Impact factor: 9.867

10.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

View more
  104 in total

1.  The zinc finger-associated SCAN box is a conserved oligomerization domain.

Authors:  A J Williams; S C Blacklow; T Collins
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex.

Authors:  Z Yang; S H Hong; M L Privalsky
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

3.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.

Authors:  H Y Kao; M Downes; P Ordentlich; R M Evans
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

4.  Unique forms of human and mouse nuclear receptor corepressor SMRT.

Authors:  P Ordentlich; M Downes; W Xie; A Genin; N B Spinner; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 5.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

6.  NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat.

Authors:  S A Mackler; L Korutla; X Y Cha; M J Koebbe; K M Fournier; M S Bowers; P W Kalivas
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

7.  The SMRT corepressor is a target of phosphorylation by protein kinase CK2 (casein kinase II).

Authors:  Y Zhou; W Gross; S H Hong; M L Privalsky
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

8.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

9.  Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?

Authors:  J D Licht
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 10.  All in the family: the BTB/POZ, KRAB, and SCAN domains.

Authors:  T Collins; J R Stone; A J Williams
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.